U.S., June 18 -- ClinicalTrials.gov registry received information related to the study (NCT07655219) titled 'Assessment of the Efficacy of a Highly Standardized Ginger and Perilla Nutraceutical (Dispepril(R)) in Improving Gastric and Intestinal Symptoms in Patients With Functional Dyspepsia' on June 10.
Brief Summary: This multicenter, prospective, randomized, controlled clinical trial aims to evaluate the efficacy of a nutraceutical treatment containing highly standardized extracts of ginger (Zingiber officinale) and perilla (Perilla frutescens) (Dispepril(R), Pharmextracta S.p.A. Pontenure, Italy) in improving gastric and intestinal symptoms in adults with functional dyspepsia. The study will assess the non-inferiority of Dispepril(R) co...